The SD-809 (deutetrabenazine) treatment by Israel’s Teva for Huntington disease has been approved by the US FDA.
Huntington’s treatment gets US approval
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.
The SD-809 (deutetrabenazine) treatment by Israel’s Teva for Huntington disease has been approved by the US FDA.